These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 35292039)

  • 21. Association between changes in bodyweight and cardiovascular disease risk factors among obese Japanese patients with type 2 diabetes.
    Yoshimura R; Nakagami T; Hasegawa Y; Oya J; Babazono T
    J Diabetes Investig; 2022 Sep; 13(9):1560-1566. PubMed ID: 35417613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and participant characteristics for a randomized effectiveness trial of an intensive lifestyle intervention to reduce cardiovascular risk in adults with type 2 diabetes: The I-D-HEALTH study.
    Liss DT; Finch EA; Gregory DL; Cooper A; Ackermann RT
    Contemp Clin Trials; 2016 Jan; 46():114-121. PubMed ID: 26611433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study.
    Kaze AD; Santhanam P; Musani SK; Ahima R; Echouffo-Tcheugui JB
    J Am Heart Assoc; 2021 Apr; 10(7):e016947. PubMed ID: 33728932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A very low-carbohydrate, low-saturated fat diet for type 2 diabetes management: a randomized trial.
    Tay J; Luscombe-Marsh ND; Thompson CH; Noakes M; Buckley JD; Wittert GA; Yancy WS; Brinkworth GD
    Diabetes Care; 2014 Nov; 37(11):2909-18. PubMed ID: 25071075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity, cardiovascular risk, and lifestyle: cross-sectional and prospective analyses in a nationwide Spanish cohort.
    Valenzuela PL; Santos-Lozano A; Saco-Ledo G; Castillo-García A; Lucia A
    Eur J Prev Cardiol; 2023 Oct; 30(14):1493-1501. PubMed ID: 37317985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiorespiratory Fitness, BMI, Mortality, and Cardiovascular Disease in Adults with Overweight/Obesity and Type 2 Diabetes.
    Wills AC; Vazquez Arreola E; Olaiya MT; Curtis JM; Hellgren MI; Hanson RL; Knowler WC
    Med Sci Sports Exerc; 2022 Jun; 54(6):994-1001. PubMed ID: 35175249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study.
    de Ritter R; Sep SJS; van der Kallen CJH; Schram MT; Koster A; Kroon AA; van Greevenbroek MMJ; Eussen SJPM; Dagnelie PC; de Jong M; Vos RC; Woodward M; Bots ML; Peters SAE; Stehouwer CDA
    BMJ Open Diabetes Res Care; 2019; 7(1):e000787. PubMed ID: 31798903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicted lean body mass, fat mass, and heart failure in patients with type 2 diabetes mellitus.
    Tang X; Zhu Y; Xing Z
    Am Heart J; 2023 Mar; 257():78-84. PubMed ID: 36528115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in predicted lean body mass, appendicular skeletal muscle mass, and body fat mass and cardiovascular disease.
    Kim SR; Lee G; Choi S; Oh YH; Son JS; Park M; Park SM
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1113-1123. PubMed ID: 35212175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association between muscle-to-fat ratio and cardiometabolic risks: The China National Health Survey.
    He H; Pan L; Wang D; Liu F; Du J; Pa L; Wang X; Cui Z; Ren X; Wang H; Peng X; Zhao J; Shan G
    Exp Gerontol; 2023 May; 175():112155. PubMed ID: 36940562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations Between Cardiovascular Risk Factors and Audiometric Hearing: Findings From the Canadian Longitudinal Study on Aging.
    Mick PT; Kabir R; Pichora-Fuller MK; Jones C; Moxham L; Phillips N; Urry E; Wittich W
    Ear Hear; 2023 Nov-Dec 01; 44(6):1332-1343. PubMed ID: 37122082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial.
    Look AHEAD Research Group
    Lancet Diabetes Endocrinol; 2014 Oct; 2(10):801-9. PubMed ID: 25127483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations of overweight and obesity with the risk of cardiovascular disease according to metabolic risk factors among middle-aged Japanese workers: The Aichi Workers' cohort study.
    Al-Shoaibi AAA; Li Y; Song Z; Hong YJ; Chiang C; Nakano Y; Hirakawa Y; Matsunaga M; Ota A; Tamakoshi K; Yatsuya H
    Obes Res Clin Pract; 2024; 18(2):101-108. PubMed ID: 38480065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does metformin therapy influence the effects of intensive lifestyle intervention? Exploring the interaction between first line therapies in the Look AHEAD trial.
    Terada T; Boulé NG
    Metabolism; 2019 May; 94():39-46. PubMed ID: 30653978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial.
    ; Pi-Sunyer X; Blackburn G; Brancati FL; Bray GA; Bright R; Clark JM; Curtis JM; Espeland MA; Foreyt JP; Graves K; Haffner SM; Harrison B; Hill JO; Horton ES; Jakicic J; Jeffery RW; Johnson KC; Kahn S; Kelley DE; Kitabchi AE; Knowler WC; Lewis CE; Maschak-Carey BJ; Montgomery B; Nathan DM; Patricio J; Peters A; Redmon JB; Reeves RS; Ryan DH; Safford M; Van Dorsten B; Wadden TA; Wagenknecht L; Wesche-Thobaben J; Wing RR; Yanovski SZ
    Diabetes Care; 2007 Jun; 30(6):1374-83. PubMed ID: 17363746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes.
    Bertoni AG; Wagenknecht LE; Kitzman DW; Marcovina SM; Rushing JT; Espeland MA;
    Obesity (Silver Spring); 2012 Jul; 20(7):1511-8. PubMed ID: 21959345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physical Activity and Weight Loss Among Adults With Type 2 Diabetes and Overweight or Obesity: A Post Hoc Analysis of the Look AHEAD Trial.
    Huang Z; Zhuang X; Huang R; Liu M; Xu X; Fan Z; Dai R; Li H; Xiong Z; Guo Y; Liang Q; Liao X
    JAMA Netw Open; 2024 Feb; 7(2):e240219. PubMed ID: 38386318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aerobic, resistance, or combined exercise training and cardiovascular risk profile in overweight or obese adults: the CardioRACE trial.
    Lee DC; Brellenthin AG; Lanningham-Foster LM; Kohut ML; Li Y
    Eur Heart J; 2024 Apr; 45(13):1127-1142. PubMed ID: 38233024
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.